RNA-binding protein CRD-BP in melanocyte biology
RNA-binding protein CRD-BP in melanocyte biology
批准号:
8996553
负责人:
Vladimir S. Spiegelman
金额:
$31.94万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-11 至 2018-01-31
关键词:
AddressBindingBiological AssayBiologyCell Culture TechniquesControlled EnvironmentDataDevelopmentDifferentiation and GrowthEmbryoEnvironmentEvaluationFoundationsGene ExpressionGenesGenetic TranscriptionGoalsGrowthGrowth and Development functionHealthHypoxiaIGF2 geneKnock-outKnowledgeLightMalignant - descriptorMessenger RNAMicroRNAsMusPhysiologicalPlayPreventionRNA-Binding ProteinsRegulationRoleSignal PathwaySignal TransductionSiteSkinTrans-ActivatorsTranscriptUntranslated RegionsUp-RegulationZebrafishbaseblood pressure regulationc-myc Genescis acting elementknock-downmRNA DecaymRNA Stabilitymelanocytemelanomamicrophthalmia-associated transcription factornovelpleiotropismpreventresponsetau Proteinstranscription factorultraviolet irradiation
中文摘要
描述(申请人提供):这里提出的研究目标是了解RNA结合蛋白CRD-BP在黑素细胞生物学中的作用。微小黑色素瘤相关转录因子(MITF)是黑素细胞发育的主要调节因子,也是恶性黑色素瘤生存和生长的关键因子。因此,了解控制MITF表达和功能的机制是极其重要的,因为它将识别黑素细胞发育和分化的关键成分。MRNA周转调控是近年来出现的一种控制基因表达的主要机制。信使核糖核酸的衰减率受发育和环境信号的影响,并由信使核糖核酸中的顺式作用元件和反式作用因子决定,如miRNAs和RNA结合蛋白。我们已经证明MITF mRNA是CRD-BP的一个新的黑素细胞/黑色素瘤特异性靶点。我们证明了CRD-BP直接与MITF mRNA的3‘-UTR结合,并阻止miR-340与其靶点的结合,从而稳定了MITF转录本,从而诱导了MITF的表达和活性。CRD-BP是一种多功能的RNA结合蛋白,可识别MITF、bTrCP1、Gli1、c-myc、IGF2、tau等基因的mRNAs。我们发现CRD-BP是b-catenin/Tcf和c-myc转录因子的新靶点。我们的初步数据表明,作为对b-catenin信号的响应,CRD-BP结合并稳定c-myc和bTrCP1的mRNAs。CRD-BP在b-catenin信号诱导c-myc和bTrCP1的表达过程中起着至关重要的作用。因此,b-catenin/Tcf对CRD-BP的转录上调可能有助于Wnt信号通路的多效性,并可能为CRD-BP在依赖于Wnt/b-catenin的黑素细胞的发育中具有重要作用的假设提供基础。我们的初步结果表明,除了Wnt信号的调控外,低氧还可以诱导CRD-BP的表达。考虑到皮肤的生理缺氧环境,这种新的CRD-BP表达和功能调节模式可能在黑素细胞的生长和发育中发挥重要作用。我们推测,通过影响MITF和其他mRNAs的稳定性,CRD-BP对正常的黑素细胞发育是必不可少的。我们建议研究CRD-BP在黑素细胞生物学中的作用,以及它在黑素细胞中的调节机制和意义。根据这些目标,具体目标是:1.明确CRD-BP在黑素细胞生长和分化中的需求。2.阐明缺氧对CRD-BP的调节机制(S)。3.分析缺氧对黑素细胞CRD-BP调节的病理生理意义。
英文摘要
DESCRIPTION (provided by applicant): The goal of studies proposed here is to understand the role of the role of RNA-binding protein, CRD-BP, in melanocyte biology. Microphtalmia-associated transcription factor (MITF) is a principal regulator of melanocyte development and a pivotal factor in the survival and growth of malignant melanomas. Therefore understanding the mechanisms controlling the expression and function of MITF is extremely important as it will identify key components for melanocyte development, and differentiation. Regulation of mRNA turnover emerged in recent years as a major mechanism controlling gene expression. mRNA decay rates are responsive to developmental and environmental signals and dictated by cis-acting elements within the mRNA and by trans-acting factors, such as miRNAs and RNA-binding proteins. We have shown that MITF mRNA is a novel melanocyte/melanoma-specific target of CRD-BP. We demonstrated that CRD-BP directly binds to the 3'-UTR of MITF mRNA and prevents the binding of miR-340 to its target sites resulting in stabilization of the MITF transcript that leads to induction of MITF expression and activities. CRD-BP is a multifunctional RNA-binding protein that recognizes the mRNAs of MITF, bTrCP1, Gli1, c-myc, IGF2, tau, and other genes. We identified CRD-BP as a novel target of b-catenin/Tcf, and c-myc transcription factors. Our preliminary data demonstrate that in response to b-catenin signaling, CRD-BP binds and stabilizes mRNAs of c-myc and bTrCP1. CRD-BP is essential for induction of c-myc and bTrCP1 by b-catenin signaling. Transcriptional upregulation of CRD-BP by b-catenin/Tcf may therefore contribute to pleiotropic effects of the Wnt signaling pathway and could provide the foundation for the hypothesis that CRD-BP might have a significant function in Wnt/b-catenin-dependent melanocyte development. In addition to the regulation by Wnt signaling, our preliminary results show that hypoxia also induces the expression of CRD-BP. Taking into consideration the physiologically hypoxic environment of the skin, this novel mode of regulation of expression and function of CRD-BP could play a significant role in melanocyte growth and development. We hypothesize that by influencing the stability of MITF and other mRNAs, CRD-BP is essential for normal melanocyte development. We propose to study the role of CRD-BP in melanocyte biology, and the mechanisms and significance of its regulation in melanocytes. Pursuant to these goals, the specific aims are: 1. To define the requirement for CRD-BP in the growth and differentiation of melanocytes. 2. To delineate the mechanism(s) of CRD-BP regulation by hypoxia. 3. To analyze the (patho)physiologic significance of CRD-BP regulation by hypoxia in melanocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role and mechanisms of IGF2BP1 in melanoma pathogenesis
-
批准号:10530604
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2019
-
负责人:Vladimir S. Spiegelman
-
依托单位:
Role and mechanisms of IGF2BP1 in melanoma pathogenesis
-
批准号:10304172
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2019
-
负责人:Vladimir S. Spiegelman
-
依托单位:
Role and mechanisms of IGF2BP1 in melanoma pathogenesis
-
批准号:10064140
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2019
-
负责人:Vladimir S. Spiegelman
-
依托单位:
Role and mechanisms of IGF2BP1 in melanoma pathogenesis
-
批准号:9911798
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2019
-
负责人:Vladimir S. Spiegelman
-
依托单位:
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis
-
批准号:8813074
-
项目类别:
-
资助金额:$3.67万
-
财政年份:2014
-
负责人:Vladimir S. Spiegelman
-
依托单位:
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis
-
批准号:9076794
-
项目类别:
-
资助金额:$17.01万
-
财政年份:2014
-
负责人:Vladimir S. Spiegelman
-
依托单位:
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis
-
批准号:8974822
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2014
-
负责人:Vladimir S. Spiegelman
-
依托单位:
RNA-binding protein CRD-BP in melanocyte biology
-
批准号:9088551
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2013
-
负责人:Vladimir S. Spiegelman
-
依托单位:
RNA-binding protein CRD-BP in melanocyte biology
-
批准号:8437734
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2013
-
负责人:Vladimir S. Spiegelman
-
依托单位:
RNA-binding protein CRD-BP in melanocyte biology
-
批准号:9208744
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2013
-
负责人:Vladimir S. Spiegelman
-
依托单位:
RNA-binding protein CRD-BP in melanocyte biology
-
批准号:8793761
-
项目类别:
-
资助金额:$6.31万
-
财政年份:2013
-
负责人:Vladimir S. Spiegelman
-
依托单位:
RNA-binding protein CRD-BP in melanocyte biology
-
批准号:8616719
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2013
-
负责人:Vladimir S. Spiegelman
-
依托单位:
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers
-
批准号:7255140
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2007
-
负责人:Vladimir S. Spiegelman
-
依托单位:
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers
-
批准号:7364183
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2007
-
负责人:Vladimir S. Spiegelman
-
依托单位:
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers
-
批准号:7755381
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2007
-
负责人:Vladimir S. Spiegelman
-
依托单位:
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers
-
批准号:8014962
-
项目类别:
-
资助金额:$26.81万
-
财政年份:2007
-
负责人:Vladimir S. Spiegelman
-
依托单位:
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers
-
批准号:7576902
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2007
-
负责人:Vladimir S. Spiegelman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: